Evidence map›Paper›PMID 20861348›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2010

Monocyte 15-lipoxygenase gene expression requires ERK1/2 MAPK activity.

Ashish Bhattacharjee, Anny Mulya, Srabani Pal, Biswajit Roy, Gerald M Feldman, Martha K Cathcart

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Vacuolar (HJournal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  5. Review
  6. Article
  7. Article
  8. Foxa2 regulates leukotrienes to inhibit Th2-mediated pulmonary inflammation.American journal of respiratory cell and molecular biology · 2013
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ashish BhattacharjeeDepartment of Cell Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Anny Mulya
Srabani Pal
Biswajit Roy
Gerald M Feldman
Martha K Cathcart
Cleveland Clinic Lerner College of Medicine · USCase Western Reserve University · USCenter for Biologics Evaluation and Research · US

Funding

REGULATION OF MONOCYTE 15-LIPOXYGENASE EXPRESSIONP01HL087018 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI MCINTYRE, THOMAS M · 2007 to 2011
$11.4M
MONOCYTE OXIDATION OF LIPOPROTEIN LIPIDSR01HL051068 · NHLBI · CLEVELAND CLINIC FOUNDATION · PI CATHCART, MARTHA K · 1995 to 2002
$778k
NHLBI NIH HHS HL051068NHLBI NIH HHS HL087018NHLBI NIH HHS P01 HL087018NHLBI NIH HHS R01 HL051068
6 · The paper itself

Abstract

IL-13 induces profound expression of 15-lipoxygenase (15-LO) in primary human monocytes. Our studies have defined the functional IL-13R complex, association of Jaks with the receptor components, and the tyrosine phosphorylation of several Stat molecules in response to IL-13. Furthermore, we identified both p38MAPK and protein kinase Cδ as critical regulators of 15-LO expression. In this study, we report an ERK1/2-dependent signaling cascade that regulates IL-13-mediated 15-LO gene expression. We show the rapid phosphorylation/activation of ERK1/2 upon IL-13 exposure. Our results indicate that Tyk2 kinase is required for the activation of ERK1/2, which is independent of the Jak2, p38MAPK, and protein kinase Cδ pathways, suggesting bifurcating parallel regulatory pathways downstream of the receptor. To investigate the signaling mechanisms associated with the ERK1/2-dependent expression of 15-LO, we explored the involvement of transcription factors, with predicted binding sites in the 15-LO promoter, in this process including Elk1, early growth response-1 (Egr-1), and CREB. Our findings indicate that IL-13 induces Egr-1 nuclear accumulation and CREB serine phosphorylation and that both are markedly attenuated by inhibition of ERK1/2 activity. We further show that ERK1/2 activity is required for both Egr-1 and CREB DNA binding to their cognate sequences identified within the 15-LO promoter. Furthermore, by transfecting monocytes with the decoy oligodeoxyribonucleotides specific for Egr-1 and CREB, we discovered that Egr-1 and CREB are directly involved in regulating 15-LO gene expression. These studies characterize an important regulatory role for ERK1/2 in mediating IL-13-induced monocyte 15-LO expression via the transcription factors Egr-1 and CREB.

Indexed as

Arachidonate 15-LipoxygenaseCREB-Binding ProteinDNA, Single-StrandedEnzyme ActivationEnzyme-Linked Immunosorbent AssayGene ExpressionGene Expression RegulationHumansImmunoblottingImmunoprecipitationInterleukin-13Mitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3MonocytesPhosphorylationPromoter Regions, GeneticArachidonate 15-LipoxygenaseCREB-Binding ProteinDNA enzyme ED5DNA, Single-StrandedInterleukin-13MAPK1 protein, humanMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3

Identifiers

PMID20861348
PMCPMC3061395
OpenAlexW2142606139

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.